Second, miR-204, -211, and -379 directly downregulate a key pathogenetic process in breast cancer metastasis, the TGF-β-induced expression of IL11. MiR-379 also inhibits TGF-β signaling through Smad2/3/4 transcription factors. This evidence concerns the gene SMAD2 and breast carcinoma.